B. Bell

发表

Antimetabolite therapy for lesser-risk B-lineage acute lymphoblastic leukemia of childhood: a report from Children's Oncology Group Study P9201.

J. Shuster, J. Kurtzberg, M. Devidas, 2007, Blood.

Phase I Trial and Pharmacokinetic (PK) and Pharmacodynamics (PD) Study of Topotecan Using a Five‐Day Course in Children with Refractory Solid Tumors: A Pediatric Oncology Group Study

J. Kurtzberg, N. Winick, C. Pratt, 1996, Journal of pediatric hematology/oncology.

Vincristine-Induced Neuropathy as the Initial Presentation of Charcot-Marie-Tooth Disease in Acute Lymphoblastic Leukemia: A Pediatric Oncology Group Study

J. Kurtzberg, V. Shashi, E. Morgan, 2003, Journal of pediatric hematology/oncology.

Dose Intensification of Methotrexate and Cytarabine During Intensified Continuation Chemotherapy for High-risk B-Precursor Acute Lymphoblastic Leukemia: POG 9406 A Report From the Children’s Oncology Group

J. Shuster, J. Kurtzberg, M. Devidas, 2014, Journal of pediatric hematology/oncology.

Neurocognitive and Neuroradiologic Central Nervous System Late Effects in Children Treated on Pediatric Oncology Group (POG) P9605 (Standard Risk) and P9201 (Lesser Risk) Acute Lymphoblastic Leukemia Protocols (ACCL0131): A Methotrexate Consequence? A Report From the Children’s Oncology Group

K. Helton, F. D. Armstrong, P. Duffner, 2014, Journal of pediatric hematology/oncology.

Phase I study of a 120-hour continuous intravenous infusion of 5-fluorouracil in pediatric patients with recurrent solid tumors: a Pediatric Oncology Group study.

J. Krischer, D. Green, B. Cushing, 1990, Medical and pediatric oncology.

Perspectives on Improving the Prevention and Treatment of Chemotherapy-Induced Nausea and Vomiting (CINV) Developing Clinically and Economically Efficient Antiemetic Regimens

M. Jahanzeb, B. Bell, 2013 .

A comparison of red blood cell thiopurine metabolites in children with acute lymphoblastic leukemia who received oral mercaptopurine twice daily or once daily: A Pediatric Oncology Group study (now The Children's Oncology Group)

J. Shuster, B. Bostrom, B. Camitta, 2004, Pediatric blood & cancer.

Prospective analysis of TEL gene rearrangements in childhood acute lymphoblastic leukemia: a Children's Oncology Group study.

C. Pui, J. Shuster, J. Kurtzberg, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chemotherapy of childhood acute lymphoblastic leukemia.

B. Bell, V. Whitehead, 1986, Developmental Pharmacology and Therapeutics.

Cognitive and academic late effects among children previously treated for acute lymphocytic leukemia receiving chemotherapy as CNS prophylaxis.

Ronald T. Brown, G. Walco, S. Lauer, 1998, Journal of pediatric psychology.

A Phase I study of acivicin in refractory pediatric solid tumors

S. Baruchel, M. Bernstein, H. Grier, 2004, Investigational New Drugs.

Clinical Trials and Observations: Antimetabolite therapy for lesser-risk B-lineage acute lymphoblastic leukemia of childhood: a report from Children's Oncology Group Study P9201

J. Shuster, M. Devidas, A. Carroll, 2013 .